New Partnership will Fund Research for ALK-Positive Non-Small Cell Lung Cancer

ALK Positive Inc. (ALK Positive) and the Lung Cancer Research Foundation (LCRF) have just announced their collaboration for ALK-positive non-small cell lung cancer (NSCLC) projects. They will pledge 750,000 dollars…

Continue Reading New Partnership will Fund Research for ALK-Positive Non-Small Cell Lung Cancer
Patient Story: Liver Transplant Allows Girl Diagnosed with Biliary Atresia to Celebrate her First Birthday
source: pixabay.com

Patient Story: Liver Transplant Allows Girl Diagnosed with Biliary Atresia to Celebrate her First Birthday

According to a recent article, a child with biliary atresia was able to celebrate her first birthday following her liver transplant. Biliary Atresia Biliary atresia is a condition occurring in…

Continue Reading Patient Story: Liver Transplant Allows Girl Diagnosed with Biliary Atresia to Celebrate her First Birthday
Study Highlights Experiences of Patients Treated with ADV7103 for Distal Renal Tubular Acidosis
source: pixabay.com

Study Highlights Experiences of Patients Treated with ADV7103 for Distal Renal Tubular Acidosis

According to a recent article, a new study is demonstrating how the effects of distal renal tubular acidosis impact a patient’s quality of life. Distal Renal Tubular Acidosis (dRTA) Distal…

Continue Reading Study Highlights Experiences of Patients Treated with ADV7103 for Distal Renal Tubular Acidosis

Phase 3 Investigation of Ampreloxetine Produces Positive Results for Neurogenic Orthostatic Hypotension

Theravance Biopharma Inc. has just released results from their 2nd Phase 3 investigation of Ampreloxetine as a therapy for symptomatic neurogenic orthostatic hypotension (nOH). Symptomatic nOH NOH is a rare…

Continue Reading Phase 3 Investigation of Ampreloxetine Produces Positive Results for Neurogenic Orthostatic Hypotension

Advocates Ask that the Same Effort Used for COVID Drug Discovery Be Used for Rare Diseases

Dr. Christopher Austin, a National Institute of Health Director for Transitional Sciences, spoke at last year’s virtual conference honoring Rare Disease Day. According to an article in the NIH Record, Dr.…

Continue Reading Advocates Ask that the Same Effort Used for COVID Drug Discovery Be Used for Rare Diseases